background
pcrbase
techniqu
diagnosi
communityacquir
sever
lower
respiratori
tract
infect
becom
standard
care
howev
rel
abil
identifi
either
atyp
bacteria
virus
caus
lrti
clinic
sampl
variou
sourc
yet
determin
object
studi
design
aim
studi
compar
diagnost
yield
nasopharyng
aspir
pulmonari
sampl
etiolog
diagnosi
sever
acut
lower
respiratori
tract
infect
multiplex
pcr
patient
adult
communityacquir
pneumonia
acut
exacerb
chronic
obstruct
pulmonari
diseas
result
obtain
concord
result
pair
sampl
discord
result
pathogen
evidenc
lower
respiratori
tract
sampl
conclus
pulmonari
sampl
similar
diagnost
sensit
viru
detect
multiplex
pcr
nasopharyng
aspir
contrast
studi
diagnost
efficaci
pulmonari
sampl
legionella
pneumophila
simpl
aspir
clearli
superior
acut
lower
respiratori
tract
infect
lrti
major
caus
morbid
mortal
worldwid
identif
caus
agent
sever
communityacquir
lrti
mandatori
effici
clinic
monitor
treatment
clinic
sign
poor
etiolog
indic
recent
two
laboratori
approach
use
one
identifi
bacteri
infect
variou
pulmonari
sampl
sputum
endotrach
aspir
bronchoalveolar
lavag
one
identifi
respiratori
virus
nasopharyng
aspir
use
gener
low
sensit
assay
viral
cultur
antigen
detect
develop
multiplex
realtim
polymerasechain
reaction
pcr
identifi
panel
viral
pathogen
preval
atyp
respiratori
bacteria
revolution
microbiolog
diagnosi
lrti
expand
rang
pathogen
identifi
includ
larg
varieti
viral
agent
sever
combin
primer
probe
use
differ
manufactur
commerci
assay
differ
perform
pathogen
group
pathogen
valid
method
easi
sinc
multiplex
may
hamper
perform
amplif
compar
singl
pcr
howev
multiplex
pcr
better
diagnost
yield
virus
standard
cell
cultur
specif
equal
pcr
may
prove
useful
bacteria
difficult
take
long
time
cultur
thu
numer
multiplexpcr
assay
combin
detect
virus
panel
fastidi
bacteria
one
run
singl
clinic
sampl
howev
rel
abil
identifi
either
atyp
bacteria
virus
caus
lrti
variou
clinic
sampl
upper
lower
respiratori
tract
yet
determin
aim
studi
compar
diagnost
yield
nasopharyng
aspir
pulmonari
sampl
etiolog
diagnosi
sever
lrti
adult
hospitalis
intens
care
unit
univers
hospit
tour
enrol
continu
seri
adult
age
year
first
two
day
follow
admiss
intens
care
unit
univers
hospit
tour
sever
communityacquir
pneumonia
cap
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
patient
recruit
januari
januari
cap
defin
presenc
new
pulmonari
infiltr
chest
radiographi
associ
least
one
follow
clinic
symptom
fever
hypothermia
cough
without
sputum
short
breath
crackl
sound
lung
auscult
exacerb
copd
defin
symptomat
respiratori
deterior
arteri
ph
need
oxygen
therapi
lmin
tabl
nasopharyng
aspir
npa
lower
respiratori
tract
lrt
sampl
collect
patient
time
icu
admiss
npa
dispos
cathet
connect
mucu
extractor
insert
one
nostril
depth
cm
drawn
back
appli
gentl
suction
lrt
sampl
consist
induc
sputum
endotrach
aspir
bronchoalveolar
lavag
depend
clinic
statu
patient
initi
sent
laboratori
bacteri
cultur
intend
time
frame
berween
collect
maximum
day
qualiti
sputum
endotrach
sampl
assess
microscop
examin
accord
bartlett
cytolog
criteria
sampl
less
squamou
epitheli
cell
magnif
consid
repres
lower
respiratori
secret
eight
sampl
fill
criteria
discard
analysi
set
result
made
avail
clinician
discrep
result
discuss
especi
specif
treatement
could
indic
instanc
influenza
legionnella
infect
observ
nonintervent
studi
addit
sampl
perform
patient
legal
repres
receiv
written
inform
letter
nonopposit
studi
approv
ethic
committe
french
societi
intens
care
call
srlf
de
de
langu
clinic
biolog
data
store
anonym
databas
sampl
pretreat
avoid
problem
link
viscos
prevent
nonspecif
inhibit
pcr
reaction
npa
dilut
equal
volum
steril
isoton
salin
solut
sputum
endotrach
aspir
pretreat
equal
volum
eurobio
franc
min
room
temperatur
centrifug
min
g
supernat
discard
replac
equival
volum
steril
water
vortex
type
sampl
frozen
use
dna
rna
extract
use
advanc
xl
automat
extractor
qiagen
germani
nucleic
acid
extract
pretreat
sampl
elut
final
volum
sampl
analys
use
cemark
multiplex
molecular
assay
pathofind
netherland
assay
base
multiplex
ligationdepend
probe
amplif
techniqu
allow
simultan
qualit
detect
four
bacteria
legionella
pneumophila
chlamydophila
pneumonia
mycoplasma
pneumonia
bordetella
pertussi
respiratori
virus
influenza
b
viru
respiratori
syncyti
viru
b
parainfluenza
viru
coronaviru
rhinovirusenteroviru
human
metapneumoviru
adenoviru
human
bocaviru
assay
manufactur
recommand
indic
varieti
specimen
suitabl
diagnosi
viral
andor
bacteri
infect
respiratori
tract
list
includ
nasopharyng
aspir
sputum
endotrach
aspir
bronchoalveolar
lavag
assay
perform
lightcycl
roch
switzerland
accord
manufactur
instruct
categor
variabl
compar
use
chisquar
fisher
exact
test
appropri
pvalu
consid
statist
signific
frequenc
percentag
sensit
manual
calcul
elig
patient
avail
pair
nasopharyng
aspir
pulmonari
sampl
includ
studi
eightyon
patient
hospitalis
cap
exacerb
copd
primari
clinic
characterist
patient
shown
tabl
pulmonari
sampl
consist
induc
sputum
endotrach
aspir
seven
bal
analys
togeth
group
denomin
lrt
lower
respiratori
tract
sampl
median
time
npa
lrt
sampl
collect
day
rang
day
indic
two
sampl
collect
day
obtain
concord
result
pair
sampl
consist
posit
neg
result
tabl
result
differ
pair
sampl
discord
defin
identif
given
respiratori
pathogen
one
pair
sampl
presenc
coinfect
two
pathogen
discord
indic
one
two
pathogen
even
identifi
one
two
sampl
discord
result
pathogen
evidenc
lrt
sampl
tabl
identifi
least
one
respiratori
pathogen
patient
singl
infect
dual
infect
total
pathogen
differ
preval
respiratori
pathogen
patient
underli
chronic
respiratori
diseas
without
detect
chlamydophila
pneumonia
bordetella
pertussi
parainfluenza
viru
among
virus
bacteria
investig
assay
among
npa
posit
one
pathogen
two
among
lrt
sampl
posit
one
pathogen
two
identifi
detect
pathogen
type
sampl
nine
npa
lrt
sampl
correspond
discord
pair
sampl
tabl
percentag
posit
sampl
npa
lrt
compar
respect
p
identifi
metapneumoviru
respiratori
syncyti
viru
npa
lrt
sampl
posit
case
three
six
parainfluenza
viru
infect
three
five
bocaviru
type
posit
npa
contrast
two
influenza
viru
infect
detect
lrt
sampl
signific
differ
detect
rate
npa
lrt
sampl
respiratori
virus
contrast
detect
one
six
legionella
pneumophila
infect
studi
npa
wherea
detect
lrt
sampl
sampl
method
aspir
versu
wash
swab
localis
nasal
nasopharyng
oropharyng
pulmonari
optim
etiolog
diagnosi
lrti
still
subject
debat
assess
sampl
method
hamper
mani
studi
limit
factor
type
popul
children
versu
adult
underli
condit
patient
immun
compet
versu
immun
compromis
type
respiratori
diseas
upper
lower
respiratori
tract
infect
spectrum
detect
respiratori
pathogen
bacteria
versu
virus
investig
diagnost
efficaci
nasopharyng
aspir
versu
pulmonari
sampl
welldefin
adult
popul
communityacquir
sever
lrti
found
diagnost
approach
gave
similar
diagnost
yield
respiratori
virus
discord
sever
studi
report
better
perform
lrt
sampl
diagnosi
viral
infect
adult
studi
base
nasal
throat
nasopharyng
swab
use
npa
shown
provid
better
yield
swab
even
adult
accur
comparison
must
also
consid
qualiti
socal
pulmonari
sampl
deal
sputum
contamin
saliva
may
skew
result
assess
pulmonari
origin
sputum
document
mani
studi
studi
assess
qualiti
pulmonari
sampl
found
sputum
endotrach
aspir
bona
fide
pulmonari
sampl
superior
lower
upper
respiratori
tract
sampl
diagnosi
sever
infuenza
suggest
sever
author
see
differ
studi
sinc
influenza
viru
infect
diagnos
specimen
use
molecular
detect
greatli
improv
diagnosi
four
atyp
bacteria
test
cultur
requir
specif
growth
media
slow
fastidi
especi
sinc
antibiot
suscept
routin
requir
bacteria
legionnair
diseas
affect
cap
case
admit
icu
everi
year
given
sever
diseas
rapid
reliabl
diagnosi
need
adapt
clinic
manag
detect
urinari
antigen
l
pneumophila
serotyp
use
diagnosi
suffici
sensit
studi
one
case
legionellosi
gave
neg
result
urinari
antigen
test
posit
pcr
lrt
sampl
compar
studi
npa
versu
lrt
sampl
highlight
clear
superior
pulmonari
sampl
diagnosi
l
pneumophila
infect
five
six
lpneumophila
detect
pulmonari
sampl
result
accord
studi
indic
throat
nasopharyng
swab
reliabl
molecular
detect
legionella
clinician
awar
absenc
detect
legionella
pneumophila
pcr
nasopharyng
specimen
exclud
legionellosi
pcr
lrt
sampl
perform
definit
diagnosi
found
lrt
specimen
similar
diagnost
sensit
viru
detect
multiplex
pcr
npa
contrast
diagnost
efficaci
pulmonari
sampl
legionella
pneumophila
npa
clearli
superior
author
suggest
sputum
even
prefer
molecular
detect
virus
howev
sampl
method
need
standardis
obtain
lrt
specimen
good
qualiti
term
contamin
saliva
along
pretreat
procedur
extract
develop
accur
pointofcar
test
respiratori
virus
list
prioriti
world
health
organ
remplac
empir
antibimicrobi
use
thu
prevent
emerg
resist
syndrom
approach
laboratori
assay
driven
develop
multiplex
pcrbase
techniqu
associ
detect
larg
panel
virus
along
sever
atyp
bacteria
pcrbase
techniqu
perform
hour
much
sensit
previou
assay
base
antigen
detect
mani
tabl
analysi
respiratori
pathogen
test
result
pair
nasopharyng
aspir
npa
lower
respiratori
tract
sampl
lrt
sampl
instanc
specif
recommend
pertain
type
sampl
use
assay
although
appear
upper
lower
respiratori
tract
sampl
perform
differ
pathogen
way
highlight
superior
pulmonari
sampl
detect
l
pneumophila
compar
studi
need
defin
optim
sampl
detect
limit
respiratori
pathogen
interest
lrti
help
refin
exist
panel
respiratori
pathogen
base
type
patient
sampl
improv
etiolog
diagnosi
sr
conduct
viral
experi
help
clb
cl
coordin
collect
clincic
specimen
help
al
jm
sr
an
cl
contribut
equal
analysi
dg
ag
initi
studi
plan
experiment
design
contribut
write
paper
author
read
approv
final
manuscript
none
none
observ
nonintervent
studi
addit
sampl
perform
patient
legal
repres
receiv
written
inform
letter
nonopposit
studi
approv
ethic
committe
french
societi
intens
care
call
srlf
de
de
langu
clinic
biolog
data
store
anonym
databas
